argenx SE
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
15 sep 2014 - 07:02
Statutaire naam
argenx SE
Titel
arGEN-X appoints Petercam NV as Liquidity Provider to facilitate trading on Euronext Brussels
Bericht
15 September 2014
Breda, the Netherlands / Ghent, Belgium - arGEN-X N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, announced today that it has appointed Petercam NV as a liquidity provider for the Company's common shares currently listed on Euronext Brussels under the trading symbol ARGX.
A liquidity provider facilitates the buying and selling of shares in order to narrow the difference between the bid and ask prices of a traded security. The liquidity provider's goal is to improve the marketability of the shares, enabling shareholders to more efficiently trade in the Company's common stock so that in normal circumstances adequate liquidity can be maintained. The agreement between Petercam NV and the Company is compliant with Euronext Rule Book for liquidity providers. The agreement is effective as of 18 September 2014.
Gerelateerde downloads
Datum laatste update: 02 september 2024